Literature DB >> 14567457

Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002.

S Toracchio1, L Marzio.   

Abstract

BACKGROUND: Antibiotic resistance of Helicobacter pylori is the most common reason for failure in its eradication. AIM: To determine the incidence of primary and secondary resistance to tinidazole, clarithromycin and amoxycillin in Helicobacter pylori isolates from dyspeptic patients in central Italy and to evaluate the modifications of resistance over the period from 1998 to 2002.
METHODS: H. pylori strains were isolated from antral biopsies taken during upper endoscopy in 406 dyspeptic patients with no previous therapy against H. pylori, and in 96 patients who had already undergone one or more triple therapies. Antibiotic susceptibility test was performed using the screening agar method and agar dilution method.
RESULTS: Overall primary resistance to tinidazole, clarithromycin and amoxycillin was 36.7, 23.4 and 0.2%, respectively. Secondary resistance rates were: tinidazole 69.8%, clarithromycin 82.3% and amoxycillin 1%. Resistance to clarithromycin was often associated with tinidazole resistance and was significantly higher in female patients (p<0.05). Primary and secondary antibiotic resistance did not change during the 4 years of observation.
CONCLUSIONS: The dyspeptic population with H. pylori infection in central Italy shows high levels of antibiotic resistance. Primary resistance to clarithromycin is most frequent in female patients. In patients with secondary resistance, dual resistance to clarithromycin and tinidazole is found in the majority of cases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14567457     DOI: 10.1016/s1590-8658(03)00265-2

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  19 in total

Review 1.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh.

Authors:  Shamsun Nahar; Asish K Mukhopadhyay; Rasel Khan; Mian Mashhud Ahmad; Simanti Datta; Santanu Chattopadhyay; Swapan Chandra Dhar; Shafiqul Alam Sarker; Lars Engstrand; Douglas E Berg; G Balakrish Nair; Motiur Rahman
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

3.  Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults.

Authors:  Jong Hwa Lee; Ji-Hyun Shin; Im Hwan Roe; Seung Ghyu Sohn; Jung Hun Lee; Geun Ho Kang; Han-Ki Lee; Byeong Chul Jeong; Sang Hee Lee
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  Antimicrobial effects of antioxidants with and without clarithromycin on Helicobacter pylori.

Authors:  Archana Chatterjee; Debasis Bagchi; Taharat Yasmin; Sidney J Stohs
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

5.  Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran.

Authors:  Shohreh Farshad; Abdolvahab Alborzi; Aziz Japoni; Reza Ranjbar; Kazem Hosseini Asl; Parisa Badiee; Maneli Amin Shahidi; Marziyeh Hosseini
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

6.  Characterization of clarithromycin resistance in isolates of Helicobacter pylori from the UAE.

Authors:  Mubarak S Alfaresi; Abida A Elkoush
Journal:  Indian J Gastroenterol       Date:  2010-07-25

Review 7.  How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?

Authors:  Enzo Ierardi; Floriana Giorgio; Giuseppe Losurdo; Alfredo Di Leo; Mariabeatrice Principi
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

8.  Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori.

Authors:  Norazah Ahmad; Wan-Rasinah Zakaria; Sheikh-Anwar Abdullah; Ramelah Mohamed
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

9.  Incidence of Helicobacter pylori infection and their clarithromycin-resistant strains in otitis media with effusion regarding phenotypic and genotypic studies.

Authors:  Nahla A Melake; Ghada H Shaker; Magdy A Salama
Journal:  Saudi Pharm J       Date:  2012-03-03       Impact factor: 4.330

Review 10.  The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis.

Authors:  Angelo Zullo; Vincenzo De Francesco; Cesare Hassan; Sergio Morini; Dino Vaira
Journal:  Gut       Date:  2007-06-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.